Saturday, April 9, 2011

 No statistically significant association of plasma clusterin levels with Alzheimer's
( apolipoprotein J )
Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.


Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.

Clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with Alzheimer disease (AD), and have been suggested to be involved in the pathogenesis of AD. "Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression in AD, suggesting its possible use as a biomarker of AD," according to background information in the article. 
The researchers found that the likelihood of prevalent AD increased with increasing plasma levels of clusterin, with the odds increased by 63 percent for every standard deviation increase in clusterin levels, after adjusting for age, sex, education level, apolipoprotein E status, diabetes, smoking, coronary heart disease, and hypertension. Among patients with AD, higher clusterin levels were associated with more severe disease.   Read more: medilexicon.com

Omega-3 is safe and beneficial for infants

High doses of the omega-3 fatty acid DHA in baby formula or breast milk may have ‘modest, positive effects’ on the growth of the pre-term infants, including increased length, says a new study from Australia. Read morenutraingredients.com

No comments:

Post a Comment